ABBOTT RAPID DX NORTH AMERICA LLC ECAT Laboratory Award

Award NoticeAwarded

This federal contract opportunity has been awarded to on February 5, 2026.

Award Information

This solicitation resulted in an award to for approximately $30,000,000 on February 5, 2026. Similar contracts are typically issued by DEPT OF DEFENSE under 325413 (In-Vitro Diagnostic Substance Manufacturing).

Award Number
SPE2DF26D0007
Award Amount
$30,000,000
Award Date
February 5, 2026

Key Takeaways

  • No response deadline specified - contact the agency for details
  • Full and open competition - all businesses eligible to bid
  • Work to be performed in PHILADELPHIA, PA
  • Industry: In-Vitro Diagnostic Substance Manufacturing

Contract Details

Notice ID
SPE2DF-26-D0007
Opportunity Type
Award Notice
Sub-Agency
DEFENSE LOGISTICS AGENCY
Office
DLA TROOP SUPPORT
Posted Date
Tuesday, February 10, 2026
Response Deadline
Not specified
PSC Code
6640
Set-Aside
Full & Open Competition
Place of Performance
PHILADELPHIA, PA, 19111-5092
Status
Active

Description

Abbott Rapid DX LLC, Lake Mary, Florida, has been awarded a maximum $30,000,000 fixed-price with economic-price-adjustment, indefinite-delivery/indefinite-quantity contract under solicitation SPE2DE- 22-R-0006 for laboratory items for the Defense Logistics Agency Electronic Catalog. This was a competitive acquisition with 36 offers received. This is a five-year contract with no option periods. Location of performance is Florida, with a February 08, 2031, ordering period end date. Using customers are Army, Navy, Air Force, Marine Corps and federal civilian agencies. Type of appropriation is fiscal 2026 through 2031 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania (SPE2DF-26-D-0007)

Why This Opportunity Matters

The Department of DEFENSE is seeking responses for in-vitro diagnostic substance manufacturing in PHILADELPHIA, PA.